82 related articles for article (PubMed ID: 3860300)
21. Chemotherapy-induced subacute lupus erythematosus.
Guhl G; Diaz-Ley B; García-García C; Fraga J; Garcia-Diez A
Lupus; 2009 Aug; 18(9):859-60. PubMed ID: 19578115
[No Abstract] [Full Text] [Related]
22. Doxorubicin in experimental and clinical heart failure.
Christiansen S; Autschbach R
Eur J Cardiothorac Surg; 2006 Oct; 30(4):611-6. PubMed ID: 16901709
[TBL] [Abstract][Full Text] [Related]
23. Aronex Pharmaceuticals reports on annamycin phase I trial.
Expert Rev Anticancer Ther; 2001 Jun; 1(1):4. PubMed ID: 12113129
[No Abstract] [Full Text] [Related]
24. Recovery from anthracycline cardiomyopathy--how can it be explained?
Christiansen S
J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709
[No Abstract] [Full Text] [Related]
25. Anthracycline analogs: re-assessments and prospects.
Carter SK
Cancer Treat Rep; 1979 May; 63(5):935-6. PubMed ID: 455336
[No Abstract] [Full Text] [Related]
26. Liposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measures.
Chan A; Shih V; Tham Chee Kian
J Oncol Pharm Pract; 2007 Jun; 13(2):105-7. PubMed ID: 17873110
[TBL] [Abstract][Full Text] [Related]
27. Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: a case report.
Hadar A; Sheiner E; Press F; Katz A; Katz M
J Reprod Med; 2004 May; 49(5):401-3. PubMed ID: 15214719
[TBL] [Abstract][Full Text] [Related]
28. Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review).
Orditura M; Quaglia F; Morgillo F; Martinelli E; Lieto E; De Rosa G; Comunale D; Diadema MR; Ciardiello F; Catalano G; De Vita F
Oncol Rep; 2004 Sep; 12(3):549-56. PubMed ID: 15289836
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator.
Rudzinski T; Ciesielczyk M; Religa W; Bednarkiewicz Z; Krzeminska-Pakula M
Europace; 2007 May; 9(5):278-80. PubMed ID: 17383986
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin liposomal pegylated: new preparation. Breast cancer: not just a question of short-term cardiac effects.
Prescrire Int; 2004 Jun; 13(71):90-1. PubMed ID: 15233142
[TBL] [Abstract][Full Text] [Related]
31. Rare skin disorder complicating doxorubicin therapy: miliaria crystallina.
Godkar D; Razaq M; Fernandez G
Am J Ther; 2005; 12(3):275-6. PubMed ID: 15891274
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor activity and toxicity of combined doxorubicin and disodium salt of methylene-1,1-diphosphonic acid].
Stukov AN; Mironiuk TN; Kon'kov SA; Krylova IM; Reztsova VV; Filov VA; Ivin BA
Vopr Onkol; 1998; 44(1):100-2. PubMed ID: 9578741
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
Working PK; Dayan AD
Hum Exp Toxicol; 1996 Sep; 15(9):751-85. PubMed ID: 8880211
[No Abstract] [Full Text] [Related]
34. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
Nakamura S; Tanaka K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
[TBL] [Abstract][Full Text] [Related]
35. [Clinical trial of epirubicin in patients with cardiologic contraindications for the use of doxorubicin].
Pawlicki M; Zuchowska-Vogelgesang B; Maciejewicz J
Przegl Lek; 1987; 44(4):414-7. PubMed ID: 3306806
[No Abstract] [Full Text] [Related]
36. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
[TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy of invasive tumors. VI. Antibiotics].
Beran M; Semonský M; Semonská S
Cesk Farm; 1979 Dec; 28(9-10):411-20. PubMed ID: 95184
[No Abstract] [Full Text] [Related]
38. Anthracyclines.
Myers C
Cancer Chemother Biol Response Modif; 1991; 12():43-9. PubMed ID: 1931452
[No Abstract] [Full Text] [Related]
39. Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
Warner E; Hedley D; Andrulis I; Myers R; Trudeau M; Warr D; Pritchard KI; Blackstein M; Goss PE; Franssen E; Roche K; Knight S; Webster S; Fraser RA; Oldfield S; Hill W; Kates R
Clin Cancer Res; 1998 Jun; 4(6):1451-7. PubMed ID: 9626462
[TBL] [Abstract][Full Text] [Related]
40. Quelamycin: a summary of phase I clinical trials.
Cortés-Funes H; Brugarolas A; Gosálvez M
Recent Results Cancer Res; 1980; 74():200-6. PubMed ID: 7444140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
